# CAndesartan vs LIsinopril Effects on the BRain

Study · id `cardio:ct-nct01984164` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01984164](<https://clinicaltrials.gov/study/NCT01984164>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01984164

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.

## Technical summary

Registry record NCT01984164. Randomized; double masking; primary purpose prevention. Start 2014-08-20 (actual); primary completion 2018-12-03 (actual). Results posted on 2021-02-21.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 176 participants (enrolled count; ClinicalTrials.gov record NCT01984164, source copy `cardio:ctgov-nct01984164-2021-02-21`, retrieved 2026-10-26)
- Started: 2014-08-20 (actual) (ClinicalTrials.gov record NCT01984164, source copy `cardio:ctgov-nct01984164-2021-02-21`, retrieved 2026-10-26)
- Primary completion: 2018-12-03 (actual) (ClinicalTrials.gov record NCT01984164, source copy `cardio:ctgov-nct01984164-2021-02-21`, retrieved 2026-10-26)
- Completion: 2018-12-03 (actual) (ClinicalTrials.gov record NCT01984164, source copy `cardio:ctgov-nct01984164-2021-02-21`, retrieved 2026-10-26)
- Results first posted: 2021-02-21 (ClinicalTrials.gov record NCT01984164, source copy `cardio:ctgov-nct01984164-2021-02-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01984164, source copy `cardio:ctgov-nct01984164-2021-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01984164-2021-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: CAndesartan vs LIsinopril Effects on the BRain
- Acronym: CALIBREX
- Condition: Hypertension
- Condition: Mild Cognitive Impairment
- Intervention (Drug): Candesartan
- Intervention (Drug): Lisinopril
- Lead sponsor: Emory University
- Lead sponsor class: OTHER
- Collaborator: National Institute on Aging (NIA)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Candesartan (`cardio:candesartan`)
- Registry intervention name matches this record: Lisinopril (`cardio:lisinopril`)
- Registry lists this organization as the lead sponsor: Emory University (`cardio:org-emory-university`)
- Registry lists this organization as a collaborator: National Institute on Aging (`cardio:nia`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial (`cardio:pubmed-32761160`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f2a8fb27a4e36283eac28c6ee30e77c4b810b7e9e72d597ee296088ef03a7151
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
